Join Our Clinical Research Study and Help Advance Osteoarthritis Treatment

Osteoarthritis is a common joint condition that affects millions of people worldwide. While treatments are available to manage symptoms, there is still much to learn about the underlying causes of osteoarthritis and how to improve treatment outcomes. That's why we're inviting patients with osteoarthritis to participate in our clinical research study and help advance our understanding of this condition.

This clinical research study aims to evaluate the safety and efficacy of a new treatment approach for osteoarthritis. Participants in the study will receive the investigational treatment designed to target the underlying causes of osteoarthritis and improve joint function and pain.

Why Participate in Our Clinical Research Study?

Participants will be closely monitored throughout the study, and any adverse events or changes in health status will be reported and addressed promptly by the study team.

By participating in our clinical research study, you will have the opportunity to receive a new treatment approach for osteoarthritis that is not yet available to the general public. You will also contribute to the advancement of osteoarthritis research, helping improve treatment outcomes for future patients.

In addition, participants in our study will receive:

  • Comprehensive medical evaluations related to osteoarthritis

  • Access to study-related medical care at no cost

  • Compensation for time and travel expenses related to study visits

How to Join Our Clinical Research Study

If you're interested in participating in our clinical research study for osteoarthritis, the first step is to contact our study team to learn more and determine your eligibility. Our team will answer any questions about the study and guide you through the screening process.

To contact our study team, call our study hotline at (915)247-2309, email us at abraham@elpasoclinicaltrials.com, or visit us in person at 1729 Weston Brent Ln, El Paso, Texas, 79935. We look forward to hearing from you and working together to advance osteoarthritis treatment.